Comprehensive analysis of the transcriptional expressions and prognostic value of S100A family in pancreatic ductal adenocarcinoma

Table 1 Drug relations of S100As

Gene	Drug relations
S100A2	Drugbank ID	Drug Name	Drug Group	Actions	Reference
	DB00768	Olopatadine	approved	Antagonist	[15]
	DB01373	Calcium	nutraceutical		[16]
	DB01593	Zinc	approved, investigational		[16]
	DB09130	Copper	approved, investigational		[17]
	DB14487	Zinc acetate	approved, investigational		[16]
	DB14533	Zinc chloride	approved, investigational	Inactivator, regulator	[16]
	DB14548	Zinc sulfate, unspecified form	approved, experimental	Inactivator, regulator	[16]
S100A4	DB00831	Trifluoperazine	approved, investigational	Inhibitor	[18]
S100A4	DB09130	Copper	approved, investigational		[17]
S100A6	DB11093	Calcium citrate	approved, investigational	Ligand	UniProt: Protein S100-A6
	DB11348	Calcium Phosphate	approved	Ligand	UniProt: Protein S100-A6
	DB14481	Calcium phosphate dihydrate	approved		UniProt: Protein S100-A6
S100A10	NA
S100A14	NA
S100A16	DB11093	Calcium citrate	approved, investigational	Ligand	UniProt: Protein S100-A16
	DB11348	Calcium Phosphate	approved	Ligand	UniProt: Protein S100-A16
	DB14481	Calcium phosphate dihydrate	approved		UniProt: Protein S100-A16

ISSN: 1471-2407